Based on our results and previous studies in women, evaluation of the S100A family as possible biomarkers of prognosis and evolution of mammary tumors in dogs could be of interest in order to evaluate whether dogs with poorer prognosis can have higher values of these proteins. Here, S100A1 is linked to breast cancer.